ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 147 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 2.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $68,000 | -43.8% | 104,071 | -6.6% | 0.00% | -100.0% |
Q4 2021 | $121,000 | -42.1% | 111,397 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $209,000 | -32.6% | 114,729 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $310,000 | -30.6% | 117,455 | -5.5% | 0.00% | -50.0% |
Q1 2021 | $447,000 | +43.3% | 124,248 | +0.3% | 0.00% | +100.0% |
Q4 2020 | $312,000 | -2.8% | 123,920 | -2.8% | 0.00% | -50.0% |
Q3 2020 | $321,000 | -25.0% | 127,477 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $428,000 | +59.1% | 130,375 | +18.9% | 0.00% | +100.0% |
Q1 2020 | $269,000 | -43.2% | 109,629 | +9.1% | 0.00% | -50.0% |
Q4 2019 | $474,000 | +9.2% | 100,512 | -0.8% | 0.00% | 0.0% |
Q3 2019 | $434,000 | -27.1% | 101,359 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $595,000 | +84.2% | 102,064 | +21.6% | 0.00% | +100.0% |
Q1 2019 | $323,000 | +99.4% | 83,902 | -3.1% | 0.00% | 0.0% |
Q4 2018 | $162,000 | -41.9% | 86,623 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $279,000 | +7.7% | 87,289 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $259,000 | -21.3% | 85,715 | +2.1% | 0.00% | 0.0% |
Q1 2018 | $329,000 | -10.1% | 83,989 | -5.1% | 0.00% | 0.0% |
Q4 2017 | $366,000 | -32.3% | 88,506 | +0.5% | 0.00% | -50.0% |
Q3 2017 | $541,000 | +6.7% | 88,088 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $507,000 | +6.7% | 81,502 | +8.9% | 0.00% | 0.0% |
Q1 2017 | $475,000 | +27.0% | 74,843 | +7.1% | 0.00% | +100.0% |
Q4 2016 | $374,000 | -99.9% | 69,892 | -0.3% | 0.00% | -50.0% |
Q3 2016 | $394,505,000 | +2.7% | 70,072 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $384,108,000 | -39.8% | 69,965 | -18.7% | 0.00% | 0.0% |
Q1 2016 | $638,000,000 | -10.8% | 86,110 | 0.0% | 0.00% | -33.3% |
Q4 2015 | $715,000,000 | +81335.1% | 86,110 | -11.6% | 0.00% | -25.0% |
Q3 2015 | $878,000 | -99.9% | 97,420 | +15.2% | 0.00% | 0.0% |
Q2 2015 | $1,014,480,000 | +34.2% | 84,540 | +20.5% | 0.00% | +33.3% |
Q1 2015 | $755,774,000 | +109.8% | 70,174 | -1.2% | 0.00% | +50.0% |
Q4 2014 | $360,198,000 | +86.7% | 71,045 | -2.8% | 0.00% | +100.0% |
Q3 2014 | $192,886,000 | -34.5% | 73,063 | -0.1% | 0.00% | 0.0% |
Q2 2014 | $294,605,000 | -13.9% | 73,103 | -2.1% | 0.00% | -50.0% |
Q1 2014 | $342,108,000 | +7.4% | 74,696 | +1.8% | 0.00% | 0.0% |
Q4 2013 | $318,482,000 | +29.1% | 73,383 | +17.4% | 0.00% | +100.0% |
Q3 2013 | $246,696,000 | +85.4% | 62,499 | -1.2% | 0.00% | 0.0% |
Q2 2013 | $133,082,000 | – | 63,289 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |